Agentix Corp. (OTCMKTS:AGTX) Sees Significant Decline in Short Interest

Agentix Corp. (OTCMKTS:AGTX) was the recipient of a significant drop in short interest in the month of April. As of April 30th, there was short interest totaling 13 shares, a drop of 87.7% from the April 15th total of 106 shares. Based on an average daily trading volume, of 314 shares, the short-interest ratio is presently 0.0 days.

Agentix Stock Performance

OTCMKTS AGTX opened at $0.04 on Thursday. Agentix has a one year low of $0.02 and a one year high of $0.06. The company’s 50 day moving average price is $0.04 and its 200 day moving average price is $0.04.

About Agentix

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. The company offers AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases.